Table 2.
Potential factors protecting children against severe SARS-CoV-2 infection
| Potential protective factor | Mechanisms |
|---|---|
| Prevention of virus exposure |
Early isolation and movement restriction -Closing schools and day-care centers in epidemics |
| Appropriate infection handling |
Trained immunity (strong innate response) due to -Live vaccines (BCG, live virus vaccines) -Frequent virus infections High ACE-2 expression metabolizing angiotensin-2 Lack of immune-senescence Good lung regeneration capacity |
| Absence of high-risk factors |
Absence of ageing related co-morbidities. Less degree of obesity, smoking |
|
High-risk group 1. Infants (< 1 y) 2. Children with pre-existing illnesses (neurological disorders, chronic lung diseases including asthma, uncorrected heart diseases, and genetic disorders) | |
ACE-2 Angiotensin converting enzyme -2; BCG Bacille Calmette-Guerin